Clincosm LogoSign in Get a demo

her2 positive breast carcinoma

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +20 more
  • Best Practice
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 5, 2023

HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • Tucson, Arizona
  • +15 more
Dec 22, 2022

Metastatic Breast Cancer, HER2 Positive Breast Carcinoma Trial in United States (Niraparib, Trastuzumab)

Recruiting
  • Metastatic Breast Cancer
  • HER2 Positive Breast Carcinoma
  • Birmingham, Alabama
  • +6 more
Dec 13, 2022

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 22, 2022

Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)

Recruiting
  • Breast Cancer
  • +7 more
  • Dendritic Cell Vaccine (DC1)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 23, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Yuma, Arizona
  • +5 more
May 25, 2022

Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I Trial in United States (DC1 Vaccine, WOKVAC Vaccine)

Recruiting
  • Breast Cancer Female
  • +7 more
  • DC1 Vaccine
  • WOKVAC Vaccine
  • Tampa, Florida
  • +6 more
Apr 4, 2022

Breast Tumors, Breast Diseases, Capecitabine Trial in China (RC48-ADC, Lapatinib, Capecitabine)

Recruiting
  • Breast Neoplasms
  • +5 more
  • Beijing, Beijing, China
  • +66 more
Feb 18, 2022

Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage IA Breast Cancer AJCC v8
  • +21 more
  • Trastuzumab Emtansine
  • +4 more
  • Birmingham, Alabama
  • +897 more
Feb 16, 2022

Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage IA Breast Cancer AJCC v8
  • +27 more
  • Aspiration of Breast
  • Biospecimen Collection
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 29, 2021

HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Norfolk, Omaha (drug,

Active, not recruiting
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Norfolk, Nebraska
  • +2 more
Sep 1, 2021

Anti-HER2 Therapies in HER2-Positive Stage I-IV Breast Cancer

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +23 more
  • Biospecimen Collection
  • Jacksonville, Florida
    Mayo Clinic in Florida
Aug 9, 2021

Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (External Beam Radiation

Recruiting
  • Estrogen Receptor Negative
  • +11 more
  • External Beam Radiation Therapy
  • +4 more
  • Phoenix, Arizona
  • +7 more
Aug 4, 2021

HER2 Positive Breast Carcinoma, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Duarte (radiation, other,

Active, not recruiting
  • HER2 Positive Breast Carcinoma
  • +3 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +5 more
  • Duarte, California
    City of Hope Medical Center
May 17, 2021

Breast Adenocarcinoma, HER2 Positive Breast Carcinoma, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other,

Completed
  • Breast Adenocarcinoma
  • +6 more
  • Aromatase Inhibition Therapy
  • +6 more
  • Birmingham, Alabama
  • +156 more
Aug 13, 2020

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7 Trial in United States (drug,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +4 more
  • Mobile, Alabama
  • +389 more
Mar 11, 2020

Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (Fulvestrant, Laboratory

Completed
Has Results
  • Estrogen Receptor Positive
  • +7 more
  • Little Rock, Arkansas
  • +367 more
Dec 9, 2019

Pyrotinib Maleate Tablets in Treatment of Breast Cancer Positive

Unknown status
  • HER2 Positive Breast Carcinoma
    • (no location specified)
    Apr 7, 2019